4890.T
Tsubota Laboratory Incorporated
グロース · 医薬品 · 医薬品 · JP
JPY 300.00
+1.69%Year over year
Reported trailing growth
- Revenue
- -45.0%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -71.8%
- EBITDA
- —
- EPS
- -85.0%
Three-year CAGR
- Revenue
- +19.3%
- EBITDA
- +13.1%
- EBIT
- +18.6%
- Net income
- +50.9%
- EPS
- +48.2%
- Free cash flow
- -5.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026